drugset / Trial / NCT03188692
Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants
Phase 3
Completed
33 enrolled
Tanabe Pharma Corporation
The Research Foundation for Microbial Diseases of Osaka University · collab
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the safety and efficacy of an intramuscular injection of BK1310 in healthy infants.
Timeline
- Start
- 2017-06-23
- Primary completion
- 2017-11-02
- Completion
- 2018-08-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DPT-IPV-Hib | Vaccine | 0.5 ml | Intramuscular |
Indications
No indication recorded.